Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prostaglandin-E Urinary Metabolite (PGE-M) as a Predictor of Acute Appendicitis in Children

NCT07008092 is registered in ClinicalTrials.gov with KBC Split as lead sponsor.

NCT NCT07008092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07008092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prostaglandin-E Urinary Metabolite (PGE-M) as a Predictor of Acute Appendicitis in Children
Lead sponsor
KBC Split
Phase
Observational
Overall status
Recruiting
Start date
June 2, 2025
Completion date
May 1, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal pain (ap), acute appendicitis, acute appendicitis with rupture